Increased plasma malondialdehyde levels in glomerular disease as determined by a fully validated HPLC method

Nephrology Dialysis Transplantation

Volumn 14, Issue 4, 1999, Pages 946-951

  Templar, Jill ^d   Kon, Sui P ^a   Milligan, Tom P ^d   Newman, David J ^b   Raftery, Martin J ^c  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b EPSOM AND ST HELIER UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^c ROYAL LONDON HOSPITAL   (United Kingdom)

^d NONE

Author keywords

Glomerulonephritis; High performance liquid chromatography; Malondialdehyde; Reactive oxygen species; Thiobarbituric acid

Indexed keywords

ACID HYDROLASE; ANTIOXIDANT; CARBON; CREATININE; FREE RADICAL; MALONALDEHYDE; REACTIVE OXYGEN METABOLITE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRICHLOROACETIC ACID;

ACCURACY; ARTICLE; BLOOD LEVEL; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEVICE; DIABETES MELLITUS; GLOMERULONEPHRITIS; GLOMERULOPATHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; HYDROLYSIS; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MEASUREMENT; METHODOLOGY; OXIDATION; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; TECHNIQUE; TISSUE INJURY;

EID: 0032943646     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/14.4.946     Document Type: Article

References (19)

1. Aruoma Ol, Kaur H, Halliwell B. Oxygen free radicals and human diseases. J R Soc Health 1991; 111: 172-177
2. Shah SV. Role of reactive oxygen metabolites in experimental glomerular disease. Kidney Int 1989; 35; 1093-1106
3. Maher ER, Wickens DG, Griffin JFA et al. Increased free radical activity during haemodialysis? Nephrol Dial Transplant 1987; 2: 169-171
4. Davenport A, Hopton M, Bolton C. Measurement of malondialdehyde as a measure of oxygen free radical production during renal allograft transplantation and the effect on early graft function. Clin Transplant 1995; 9: 171-175
5. Uchiyama M, Mihara M. Determination of malonaldehyde precursor in tissues by the thiobarbituric acid test. Anal Biochem 1978; 86: 271-278
6. Janero DR. Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free Radical Biol Med 1990; 9: 515-540
7. Bird RP, Hung SSO, Hadley M et al. Determination of malonaldehyde in biological materials by high pressure liquid chromatography. Anal Biochem 1983; 128: 240-244
8. Díaz-Vélez CR, García-Castiñeiras S, Mendoza-Ramos E et al. Increased malondialdeyde in peripheral blood of patients with congestive heart failure. Am Heart J 1996; 131: 146-152
9. Dasgupta A, Hussain S, Ahmad S. Increased lipid peroxidation in patients on maintenance haemodialysis. Nephron 1992; 60: 56-59
10. Bird RP, Draper HH. Comparative studies on different methods of malondaldehyde determination. Methods Enzymol 1984; 105: 299-305
11. Chirico S. High-performance liquid chromatography-based thiobarbituric acid tests. Methods Enzymol 1994; 234: 314-318
12. Johnson RJ, Lovett D, Lehrer RI et al. Role of oxidants and proteases in glomerular injury. Kidney Int 1994; 45: 352-359
13. Chirico S, Smith C, Marchant C et al. Lipid peroxidation in hyperlipidaemic patients. A study of plasma using an HPLC-based thiobarbituric acid test. Free Radical Res Commun 1993; 19: 51-57
14. Draper HH, Squires EJ, Mahmoodi H et al. A comparative evaluation of thiobarbituric acid methods for the determination of malondialdehyde in biological materials. Free Radical Biol Med 1993; 15: 353-363
15. Richard MJ, Arnaud J, Jurkovitz C et al. Trace elements and lipid peroxidation abnormalities in patients with chronic renal failure. Nephron 1991; 57: 10-15
16. Paul JL, Sall ND, Soni T et al. Lipid peroxidalion abnormalities in haemodialysed patients. Nephron 1993; 64: 106-109
17. Daschner M, Lenhartz H. Böttichen D et al. Influence of dialysis on plasma lipid peroxidalion products and antioxidant levels. Kidney Int 1996; 50: 1268-1272
18. Gotoh M, Nagase S, Aoyagi K et al. Thiobarbituric acid reactive substances are increased in the subcutaneous fat tissue of patients with end-stage renal disease. Nephrol Dial Transplant 1997; 12: 713-717
19. Kosugi H, Kojima T, Kikugawa K. Characteristics of the thiobarbituric acid reactivity of human urine as a possible consequence of lipid peroxidation. Lipids 1993; 28: 337-343